Elutia
ELUT • NASDAQ
Elutia is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO C. Randal Mills, with a market cap of $45.8M.
CEOC. Randal Mills
Next Earnings
Upcoming earnings announcement for Elutia
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Revenue Estimate
$3.0M
Earnings History
Past 12 earnings reports for Elutia
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | -$0.14Est: -$0.14 | +2.1% | $3.3MEst: $3.3M | -0.9% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.19Est: -$0.15 | -26.7% | $3.3MEst: $6.7M | -50.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.26 | — | $6.3MEst: $6.6M | -4.4% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.21Est: -$0.27 | +22.2% | $6.0MEst: $7.0M | -13.2% | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.26Est: $0.00 | — | $5.5MEst: $5.9M | -7.3% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.33Est: -$0.44 | +25.0% | $5.9MEst: $6.6M | -10.3% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$1.14Est: -$0.33 | -245.5% | $6.3MEst: $6.7M | -5.4% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.75Est: -$0.41 | -82.9% | $6.7MEst: $6.1M | +9.7% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.66Est: -$0.28 | -135.7% | $5.9MEst: $6.6M | -10.3% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.50Est: -$0.54 | +7.4% | $6.1MEst: $7.3M | -16.1% | — |
| Aug 14, 2023 | Q2 2023 | -$0.65Est: -$0.29 | -124.1% | $10.3MEst: $12.5M | -17.6% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.49Est: -$0.54 | +9.3% | $13.1MEst: $13.7M | -4.7% | — |